Form 4: Carmen Chang Acquires Warrants in NeueHealth, Inc.
SEC Form 4 Filing
Carmen Chang, a director of NeueHealth, Inc., acquired warrants to purchase common stock on October 1, 2024, as disclosed in a Form 4 filing with the SEC.
Summary
- Carmen Chang, a director of NeueHealth, Inc., filed a Form 4 with the SEC.
- The filing reports the acquisition of warrants to purchase common stock of NeueHealth, Inc. on October 1, 2024.
- The warrants have an exercise price of $0.01.
- The warrants expire on April 30, 2029.
- The warrants were acquired indirectly through various NEA entities (NEA 16, NEA 17, and NEA 18 VGE).
- Chang disclaims beneficial ownership of the securities held by these NEA entities, except to the extent of any pecuniary interest.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Key Dates
| Date | Description |
|---|---|
| August 4, 2023 | Date of the Credit Agreement between the Issuer and the lenders thereto. |
| October 2, 2023 | Date of Incremental Amendment No. 1 to the Credit Agreement. |
| April 8, 2024 | Date of the Warrantholders Agreement and Incremental Amendment No. 2 to the Credit Agreement. |
| October 1, 2024 | Date of the transaction (acquisition of warrants). |
| October 2, 2024 | Deemed execution date for the transaction. |
| October 3, 2024 | Date of signature for the Form 4 filing. |
| April 30, 2029 | Expiration date of the warrants. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.